These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 45100)

  • 1. Hyperprolactinemia and polycystic ovarian syndrome.
    Tzingounis VA; Aksu MF; Tsoukalos SG
    Int J Fertil; 1979; 24(4):276-80. PubMed ID: 45100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactorrhea and hyperprolactinemia during treatment of polycystic ovary syndrome.
    Wortsman J; Hirschowitz JS
    Obstet Gynecol; 1980 Apr; 55(4):460-3. PubMed ID: 6768040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between hyperprolactinemia and polycystic ovary syndrome].
    Hámori M; Szendei G; Kovács I; Somos P
    Zentralbl Gynakol; 1987; 109(8):481-6. PubMed ID: 3111126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinaemia in polycystic ovary syndrome.
    Lunde O
    Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
    Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
    Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
    Wu X; Gu Q; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the hypothalamic origin of the polycystic ovary syndrome.
    Wortsman J; Singh KB; Murphy J
    Obstet Gynecol; 1981 Aug; 58(2):137-41. PubMed ID: 6454866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia.
    Badawy SZ; Nusbaum ML; Omar M
    Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ Study of prolactin and blood gonadotropins in amenorrheas-galactorrhea. Dynamic exploation in 13 cases].
    Schaison G; Nathan C; L'Hermite M; Gilbert-Dreyfus
    Nouv Presse Med; 1975 Mar; 4(9):644-8. PubMed ID: 805417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The gonadotropin, prolactin and sex steroid content of the blood from the inferior cavernous sinuses and the adrenal and ovarian veins of women with Itsenko-Cushing disease].
    Manusharova RA; Komissarenko IV; Iugrinov OG
    Vrach Delo; 1991 Mar; (3):71-4. PubMed ID: 2042357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin release in polycystic ovary.
    Falaschi P; del Pozo E; Rocco A; Toscano V; Petrangeli E; Pompei P; Frajese G
    Obstet Gynecol; 1980 May; 55(5):579-82. PubMed ID: 6768043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
    Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation.
    Perez-Lopez FR
    Obstet Gynecol; 1975 Nov; 46(5):621-6. PubMed ID: 812032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinemia in children during the peripubertal period--personal observations.
    Noczyńska A; Wasikowa R
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1399-404. PubMed ID: 15526718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin response to clomiphene citrate is different in hyperprolactinemic polycystic ovary syndrome and idiopathic hyperprolactinemia.
    Lewinthal D; Corenblum B; Taylor PJ
    Int J Fertil; 1987; 32(3):185-7, 191. PubMed ID: 2885281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.